Patounas Marea, Lau Esther T, Chan Vincent, Rigby Deborah, Kyle Gregory J, Khatri Jyoti, Poudel Arjun, Nissen Lisa M
PhD, BPharm, MPS, AACPA, SFHEA. Lecturer, Faculty of Health, School of Clinical Sciences, Queensland University of Technology (QUT). Brisbane (Australia).
PhD, BPharm, MPS, GCResComm, GradCertAcadPrac, SFHEA. Senior Lecturer. Faculty of Health, School of Clinical Sciences, Queensland University of Technology (QUT). Brisbane (Australia).
Pharm Pract (Granada). 2021 Jul-Sep;19(3):2376. doi: 10.18549/PharmPract.2021.3.2376. Epub 2021 Aug 2.
In Australia, polypharmacy and medication-related problems are prevalent in the community. Therefore, medicines safety initiatives such as the Home Medicines Review (HMR) service are critical to health care provision. While the evidence continues to expand around HMR service, little is known of accredited pharmacists' experiences of HMR time investment.
This study aimed to explore accredited pharmacists' experiences of HMR practice regarding time investment in the study's defined HMR Stages: 1 (initial paper-based assessment and review), 2 (in-home patient-accredited pharmacist consultation), and 3 (HMR report collation, generation, completion, and provision to the patient's General Practitioner, including any liaison time).
An electronic survey was developed and piloted by a panel of reviewers. Convenience sampling was used to distribute the final anonymous survey nationally via professional pharmacy organisations. Data were analyzed for frequency distributions and a chi-square test of independence was performed to evaluate any association between demographic variables relating to HMR time investment.
There was a total of 255 survey respondents, representing approximately 10% of national accredited pharmacist membership. The majority were experienced accredited pharmacists who had completed >100 HMRs (73%), were female (71%), and aged >40 years (60%). Regarding time investment for a typical instance of HMR, most spent: <30 minutes performing Stage 1 (46.7%), and 30-60 minutes performing Stage 2 (70.2%). In Stage 3, 40.0% invested 1-2 hours, and 27.1% invested 2-3 hours in HMR report collation and completion. Quantitative analysis revealed statistically significant (p=0.03) gender findings where females performed longer patient consultations than males (Stage 2). More HMR career experience resulted in statistically significant (p=0.01) less time performing Stage 1 (initial paper-based assessment and review); with a trend to less time performing Stage 3 (HMR report writing).
Accredited pharmacists invest significant time in performing comprehensive HMRs, especially during in-home patient consultations and during HMR report collation and completion. Their significant HMR time investment as medicines experts provides insight for program and workforce considerations and warrants further research to better understand their work processes for optimizing medicines use and improving health.
在澳大利亚,多重用药及与药物相关的问题在社区中普遍存在。因此,诸如家庭药物审查(HMR)服务等药品安全举措对于医疗保健服务至关重要。尽管围绕HMR服务的证据不断增加,但对于获得认可的药剂师在HMR时间投入方面的经验却知之甚少。
本研究旨在探讨获得认可的药剂师在研究定义的HMR阶段(1. 初始纸质评估和审查;2. 患者家中药剂师与患者的咨询;3. HMR报告整理、生成、完成并提供给患者的全科医生,包括任何联络时间)中关于时间投入的HMR实践经验。
由一组评审人员开发并试点了一项电子调查问卷。采用便利抽样通过专业药学组织在全国范围内分发最终的匿名调查问卷。对数据进行频率分布分析,并进行独立性卡方检验以评估与HMR时间投入相关的人口统计学变量之间的任何关联。
共有255名受访者参与调查,约占全国获得认可药剂师会员的10%。大多数是经验丰富的获得认可的药剂师,完成了超过100次HMR(73%),女性(71%),年龄超过40岁(60%)。对于典型的HMR案例,大多数人花费:不到30分钟进行第1阶段(46.7%),30 - 60分钟进行第2阶段(70.2%)。在第3阶段,40.0%的人投入1 - 2小时,27.1%的人投入2 - 3小时进行HMR报告整理和完成。定量分析显示出具有统计学意义(p = 0.03)的性别差异,即女性进行患者咨询的时间比男性长(第2阶段)。更多的HMR职业经验导致在第1阶段(初始纸质评估和审查)花费的时间具有统计学意义(p = 0.01)地减少;并且在第3阶段(HMR报告撰写)花费的时间有减少的趋势。
获得认可的药剂师在进行全面的HMR时投入了大量时间,尤其是在患者家中咨询以及HMR报告整理和完成期间。他们作为药品专家在HMR上投入的大量时间为项目和劳动力方面的考虑提供了见解,并且有必要进一步研究以更好地了解他们优化药物使用和改善健康的工作流程。